The impact of hypoxia on cell death pathways

2013 ◽  
Vol 41 (2) ◽  
pp. 657-663 ◽  
Author(s):  
Colin R. Lenihan ◽  
Cormac T. Taylor

Hypoxia is a frequently encountered feature of the cellular microenvironment in a number of pathophysiological processes in which programmed cell death (apoptosis) affects disease progression including, but not limited to, cancer, chronic inflammation, myocardial infarction, stroke and ischaemic acute kidney injury. In these diseases, the presence of hypoxia can significantly affect the rate of cell death and thus may make a significant contribution to disease progression. In the present review, we discuss the complex relationship that exists between the presence of hypoxia and the regulation of cell death pathways.

2018 ◽  
Vol 34 (1) ◽  
pp. 108-117 ◽  
Author(s):  
Sandhya Manohar ◽  
Panagiotis Kompotiatis ◽  
Charat Thongprayoon ◽  
Wisit Cheungpasitporn ◽  
Joerg Herrmann ◽  
...  

Nephron ◽  
2018 ◽  
Vol 140 (2) ◽  
pp. 144-147 ◽  
Author(s):  
Anne von Mässenhausen ◽  
Wulf Tonnus ◽  
Andreas Linkermann

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
V.H Schmitt ◽  
L Hobohm ◽  
T Munzel ◽  
P Wenzel ◽  
T Gori ◽  
...  

Abstract Background Diabetes mellitus (DM) represents a major cardiovascular risk factor for coronary artery disease and myocardial infarction (MI). Purpose We aimed to assess in-hospital events and time trends in MI patients with and without DM between 2005 and 2016 in Germany. Methods The nationwide German inpatient sample 2005–2016 was used for statistical analysis (source: Research Data Center (RDC) of the Federal Statistical Office and the Statistical Offices of the federal states, DRG Statistics 2005–2016, own calculations). Hospitalized MI patients were stratified for the presence of DM and the impact of DM on in-hospital events was investigated. Results A total of 3,307,703 patients with acute MI (37.6% females, 56.8% aged ≥70 years) were included in the present analysis. Of these, 1,007,326 (30.5%) patients were coded for additional DM. More MI patients with DM were female (41.2% vs. 36.0%, P<0.001) and aged 70 years or older (64.3% vs. 53.5%, P<0.001). Presence of most cardiovascular risk factors was increased in coprevalence with DM compared to non-diabetics (obesity: 14.1% vs. 7.2%, essential arterial hypertension: 60.9% vs. 52.4%, hyperlipidaemia 40.5% vs. 37.8%, P<0.001), only smoking was more frequent in people without DM (4.8% vs. 8.5%, P<0.001). Additionally, DM was associated with an elevated occurrence of comorbidities like peripheral artery disease (10.8% vs. 4.5%, P<0.001), atrial fibrillation/flutter (26.5% vs. 19.6%, P<0.001) and acute or chronic kidney disease (39.8% vs. 21.8%, P<0.001). Recurrent MI events during the first 4 weeks after previous MI were more common in MI patients with DM (0.8% vs. 0.6%, P<0.001). Pneumonia (14.9% vs. 10.2%, P<0.001), acute kidney injury (8.6% vs. 5.2%, P<0.001) and stroke (3.4% vs. 2.7%, P<0.001) were more prevalent in MI patients with DM. Mortality was significantly increased in patients with DM (13.2% vs. 12.1%, P<0.001). While the proportion of MI patients with DM increased slightly from 29.8% in 2005 to 30.7% in 2016 (β 7.04 [95% CI 4.13–9.94], P<0.001), the in-hospital mortality rate of MI patients with DM decreased substantially from 15.2% in 2005 to 11.5% in 2016 (β −0.36 [95% CI: −0.38 to −0.34], P<0.001). Confirming this results, the univariate logistic regression analyses demonstrated that DM was associated with a higher in-hospital mortality (OR 1.1 [95% CI: 1.1–1.1], P<0.001), higher risk for recurrent MI (OR 1.3 [95% CI: 1.3–1.4], P<0.001), and higher frequency of acute kidney injury (OR 1.7 [95% CI: 1.7–1.7], P<0.001). Conclusions While the proportion of MI patients with DM increased only slightly from 2005 to 2016, the in-hospital mortality decreased substantially in MI patients with DM. DM was associated with an aggravated cardiovascular risk profile, higher prevalence of comorbidities and increased in-hospital mortality during hospitalization. Funding Acknowledgement Type of funding source: Public grant(s) – National budget only. Main funding source(s): This study was supported by the German Federal Ministry of Education and Research (BMBF 01EO1503); institutional grant for the Center for Thrombosis and Hemostasis.


Phytomedicine ◽  
2021 ◽  
pp. 153541
Author(s):  
Qin Yang ◽  
Hong-mei Zang ◽  
Tian Xing ◽  
Shao-fei Zhang ◽  
Chao Li ◽  
...  

2020 ◽  
Vol 5 (10) ◽  
pp. 1700-1705 ◽  
Author(s):  
Harish Seethapathy ◽  
Sophia Zhao ◽  
Ian A. Strohbehn ◽  
Meghan Lee ◽  
Donald F. Chute ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Horng-Ruey Chua ◽  
Mark Horrigan ◽  
Elizabeth Mcintosh ◽  
Rinaldo Bellomo

The impact of isoosmolar versus low-osmolar contrast media (CM) administration on contrast-induced acute kidney injury (CI-AKI) and extended renal dysfunction (ERD) is unclear. We retrospectively examined incidences of CI-AKI and ERD in patients who received iodixanol (isoosmolar) versus iohexol (low-osmolar) during angiography for cardiac indications. Of 713 patients, 560 (cohort A), 190 (cohort B), and 172 (cohort C) had serum creatinine monitored at 3 days, 30 days, and 6 months after angiography, respectively. 18% of cohort A developed CI-AKI, which was more common with iodixanol than iohexol (22% versus 13%,P=0.006). However, patients given iodixanol were older with lower baseline estimated glomerular filtration rates (eGFR). On multivariate analysis, independent associations with higher CI-AKI risk include age >65 years, female gender, cardiac failure, ST-elevation myocardial infarction, intra-aortic balloon pump, and critical illness, but not CM type, higher CM load, oreGFR<45 mL/min/1.73 m2. 32% of cohort B and 34% of cohort C had ERD at 30 days and 6 months, while 44% and 41% of subcohorts had ERD at 90 days and 1 year, respectively. CI-AKI, but not CM type, was associated with medium- and longer-term ERD, with 3-fold higher risk. Advanced age, emergent cardiac conditions, and critical illness are stronger predictors of CI-AKI, compared with CM-related factors. CI-AKI predicts longer-term ERD.


Viruses ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 629
Author(s):  
Shannic-Le Kerr ◽  
Cynthia Mathew ◽  
Reena Ghildyal

Rhinoviruses (RVs) are the etiological agents of upper respiratory tract infections, particularly the common cold. Infections in the lower respiratory tract is shown to cause severe disease and exacerbations in asthma and COPD patients. Viruses being obligate parasites, hijack host cell pathways such as programmed cell death to suppress host antiviral responses and prolong viral replication and propagation. RVs are non-enveloped positive sense RNA viruses with a lifecycle fully contained within the cytoplasm. Despite decades of study, the details of how RVs exit the infected cell are still unclear. There are some diverse studies that suggest a possible role for programmed cell death. In this review, we aimed to consolidate current literature on the impact of RVs on cell death to inform future research on the topic. We searched peer reviewed English language literature in the past 21 years for studies on the interaction with and modulation of cell death pathways by RVs, placing it in the context of the broader knowledge of these interconnected pathways from other systems. Our review strongly suggests a role for necroptosis and/or autophagy in RV release, with the caveat that all the literature is based on RV-A and RV-B strains, with no studies to date examining the interaction of RV-C strains with cell death pathways.


2009 ◽  
Vol 76 (8) ◽  
pp. 900-906 ◽  
Author(s):  
Alexander Goldberg ◽  
Elena Kogan ◽  
Haim Hammerman ◽  
Walter Markiewicz ◽  
Doron Aronson

2018 ◽  
Vol 98 (7) ◽  
pp. 911-923 ◽  
Author(s):  
Li Gao ◽  
Ming-Ming Liu ◽  
Hong-mei Zang ◽  
Qiu-Ying Ma ◽  
Qin Yang ◽  
...  

2019 ◽  
Vol 30 (7) ◽  
pp. 488-493 ◽  
Author(s):  
Raquel B. Santos ◽  
Inês Silveira ◽  
Maria Trêpa ◽  
Bruno Brochado ◽  
Rui Magalhães ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document